Why the study?
Elevated triglycerides are an established cardiovascular risk marker associated with lipid-rich plaques, but their relationship with plaque characteristics in severe hypertriglyceridaemia is illustrated through this case.
Does intravenous insulin, heparin, and plasmapheresis rapidly reduce triglyceride levels in a patient with severe hypertriglyceridaemia?
Does intravenous insulin, heparin, and plasmapheresis rapidly reduce triglyceride levels in a patient with severe hypertriglyceridaemia?
In a patient with severe familial hypertriglyceridaemia and multivessel CAD, NIRS revealed unexpectedly low plaque lipid content, and IV insulin/heparin with plasmapheresis rapidly reduced triglyceride levels.
Answers are grounded in this paper and cite their sources.
Severe hypertriglyceridemia may not produce lipid-rich plaques; this case leaves open the association and should not change practice.
Background Elevated triglycerides have been established as a cardiovascular risk marker and the literature suggests an association with lipid-rich plaques. We report a case of severe hypertriglyceridaemia that did not result in lipid-rich atherosclerotic lesions. Case summary Coronary angiography of a 54-year-old man with a triglyceride level >113.00 mmol/L revealed severe multivessel disease. Near-infrared spectroscopy (NIRS) demonstrated a low plaque lipid content, including the maximum lipid-core burden index within 4 mm of 0 in the right coronary artery (RCA), with >90% stenosis in the middle segment. To achieve a rapid reduction in the triglyceride level, intravenous administration of insulin and heparin combined with subsequent plasmapheresis was used, and a triglyceride level of 5.79 mmol/L was achieved before discharge. Genetic testing confirmed familial hypertriglyceridaemia with a pathogenic variant in the lipoprotein lipase gene. Conclusions In a patient with severely elevated serum triglycerides and premature three-artery disease, low plaque lipid content was established with the NIRS investigation. Pharmacological management of very severe hypertriglyceridaemia with intravenous insulin and heparin therapy can rapidly decrease triglyceride levels.
No takes yet. Share an insight, caveat, or question.
Kokina et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: